Competing risks analyses for recurrence from primary breast cancer

British Journal of Cancer

Volumn 79, Issue 9-10, 1999, Pages 1508-1513

  Chapman, J W ^a   Fish, E B ^a   Link, M A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Competing risks; Prognostic factors

Indexed keywords

ADJUVANT; ESTROGEN RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RECURRENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR VOLUME;

EID: 0032974094     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690240     Document Type: Article

References (17)

1. Allison PD (1995) Survival Analysis using the SAS System: a Practical Guide pp 185-209. SAS Institute: Cary, NC
2. BMDP NC (1993) Statistical Software, PC Dynamic 7.0. Statistical Solutions: Saugua, MA
3. Chapman JW, Hanna W, Kahn HJ, Lickley HLA, Wall J, Fish EB and McCready DR (1996) Alternative multivariate modelling for time to local recurrence for breast cancer patients receiving a lumpectomy alone. Surg Oncol 5: 265-271.
4. Cox DR and Oakes D (1984) Analysis of Survival Data, pp 142-155. Chapman & Hall: London
5. Fish EB, Chapman JW and Link MA (1998) Competing causes of death for primary breast cancer. Ann Surg Oncol 5(4): 368-375.
6. Gamel JW, Vogel RL, Valaguisa P and Bonadonna G (1994) Parametric survival analysis of adjuvant therapy for stage II breast cancer. Cancer 74(9): 2483-2490
7. Gamel JW, Meyer JS and Province MA (1995) Proliferative rate by S-phase measurement may affect cure of breast carcinoma. Cancer 76(6): 1009-1018
8. Gelman R, Gelber R, Henderson IC, Coleman CN and Harris JR (1990) Improved methodology for analyzing local and distant recurrence. J Clin Oncol 8(3): 548-555
9. Kalbfleisch JD and Prentice RL (1980) The Statistical Analysis of of Failure Time Data, pp 21-38, 179-188. John Wiley: New York
10. Lagakos SW (1978) A covariate model for partially censored data subject to competing causes of failure. Appl Statist 27(3): 235-241
11. Prentice RL and Marek P (1979) A qualitative discrepancy between censored data rank tests. Biometrics 35: 861-867
12. Pritchard KI, Trudeau ME, Chapman JW, Hanna W, Kahn HJ, Murray D, Sawka CA, Mobbs BG, Andrulis I, McCready DR and Lickley HLA (1993) Prognostic variables in node-negalive breast cancer: an all subset analysis. Proc ASCO 12: 68 (Abstract)
13. Proschan F and Serfling RJ (eds) (1974) Reliability and Biometty, Statistical Analysis of Lifelength. Society for Industrial and Applied Mathematics: Philadelphia, PA
14. Rutqvist LE, Wallgren A and Nilsson BO (1984) Is breast cancer a curable disease? Cancer 53: 1793-1800
15. SAS (1993) SAS/STAT User's Guide, Version 6, 4th ed., Vol. 2, pp 997-1025. SAS Institute: Cary, NC
16. S-plus (1991) S-plus 4 Guide to Statistics, pp 697-710. Data Analysis Products Division, Math Soft: Seattle, WA
17. Veronesi U, Marubini E, Del Vecchio M, Manzari A, Andreola S, Greco M, Luini A, Merson M, Saccozzi R, Rilke F and Salvadori B (1995) Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. JNCI 87(1): 19-27